REGULATORY

• Dispensing Pharmacy Chief Nabbed for Obstruction of Public Bid
  September 4, 2023

• Japan Launches Agency for Infectious Disease Crisis Management
  September 4, 2023

• Relief Claims OK’ed for 54 More Deaths after COVID Vaccination
  September 4, 2023

• Japan Approves Pfizer’s Omicron XBB.1.5 Vaccine, Moderna’s Still under Review
  September 4, 2023

• MHLW Rejigs Organization, Infectious Disease Control Team Boots Up
  September 1, 2023

• Industry Requests Rewards for SaMDs that Help Doctors’ Workstyle Reform
  September 1, 2023

• Japan to Decide on COVID Health Funding from October, Assuming Shift to Normalcy Next Spring: Minister
  September 1, 2023

• MHLW Must Streamline Operations via DX, Improve Staff’s Work-Life Balance: Official
  September 1, 2023

• 8 New Cases of Unintentional Xocova Use Among Pregnant Patients, Adding Up to 15
  August 31, 2023

• Chuikyo Payer Rep Floats Deferred Price Cuts for PMP upon Generic Entries
  August 31, 2023

• MHLW Top Pharma Officer Remains Committed to Fast, Safe Access to Good Drugs
  August 31, 2023

• MHLW to Unveil Draft of 2nd Package Strategy for SaMD on Sept. 6
  August 31, 2023

• MHLW to Issue Development Requests for New Uses of Rituxan, Truvada, and More
  August 31, 2023

• Medical DX Office to Kick Off in September, Explore Better Use of Medical Data for Drug Discovery
  August 30, 2023

• MHLW Orders Label Revisions for Prazaxa, Smyraf, and More
  August 30, 2023

• MHLW Panel OKs Inclusion of 5-in-1 Vaccine in National Immunization Program
  August 30, 2023

• Label Revisions Ordered for CAR-T Therapies on Out-of-Spec Products
  August 30, 2023

• Japan Panel Clears GSK’s Arexvy, 1st RSV Vaccine, for Approval
  August 29, 2023

• Kazunari Asanuma to Lead MHLW Health Policy Bureau
  August 29, 2023

• MHLW to Seek Funds for Survey to Streamline Generic Manufacturing: FY2024 Request
  August 28, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• 86
• 87
• …
• Next ›
• 最終 »